Wirral University Teaching Hospital NHS Foundation Trust is an NHS Foundation Trust. It provides healthcare for people of the Wirral Peninsula and the surrounding areas of North West England and North Wales.

During the past decade, Wirral University Teaching Hospital NHS Foundation Trust conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wirral University Teaching Hospital NHS Foundation Trust" are "Arthritis, Psoriatic" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Wirral University Teaching Hospital NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Wirral University Teaching Hospital NHS Foundation Trust" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab" (1 trials), "Methotrexate" (1 trials), "Placebo" (1 trials), "Placebo Methotrexate" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wirral University Teaching Hospital NHS Foundation Trust" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wirral University Teaching Hospital NHS Foundation Trust". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wirral University Teaching Hospital NHS Foundation Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wirral University Teaching Hospital NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".